Synaptogenix Inc (NAS:SNPX) Stock News, Headlines & Updates
Synaptogenix Inc Stock News from GuruFocus
- 1
Jun 26, 2024
Synaptogenix Announces FDA Authorization of IND Application for Clinical Trial for Bryostatin-1 in Multiple Sclerosis
PRNewswire • 9:00am
May 07, 2024
Synaptogenix Applauds DEA Proposal to Reclassify Cannabis and Shares Expected Benefits to Cannasoul for Cannabinoid-Based Drug Discovery
PRNewswire • 9:00am
Apr 24, 2024
Synaptogenix Regains Compliance with Nasdaq Minimum Bid Price Requirement for Continued Listing
PRNewswire • 9:00am
Apr 09, 2024
- 1
Show
Entries
Headlines
Total 0- 1
No recent news